Topic

New Jersey

A collection of 536 issues

UnitedHealthcare's Coverage Criteria for Koselugo (Selumetinib) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Getting Koselugo Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Koselugo (selumetinib) under both medical and pharmacy benefits, with no step therapy requirements for pediatric NF1 plexiform neurofibromas. Medical necessity requires confirmed NF1 diagnosis with symptomatic, inoperable plexiform neurofibromas, baseline LVEF assessment, and ophthalmologic evaluation.

How to Get Orladeyo (Berotralstat) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Orladeyo Covered by Blue Cross Blue Shield in New Jersey Horizon Blue Cross Blue Shield of New Jersey requires prior authorization for Orladeyo (berotralstat), a specialty-tier drug for HAE prophylaxis in patients ≥12 years old. The fastest path to approval: (1) Have your allergist/immunologist submit prior

How to Get Tavneos (Avacopan) Covered by Humana in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tavneos (Avacopan) Covered by Humana in New Jersey Tavneos (avacopan) requires prior authorization from Humana for ANCA-associated vasculitis coverage. Your rheumatologist, nephrologist, or pulmonologist must submit documentation proving severe active GPA/MPA with positive ANCA testing, combination with standard therapy, and medical necessity. First step today: Have

How to Get Oxlumo (Lumasiran) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Oxlumo Coverage To get Oxlumo (lumasiran) covered by Aetna CVS Health in New Jersey: Submit prior authorization with confirmed PH1 diagnosis (genetic AGXT testing or liver enzyme analysis), specialist prescription from nephrologist/geneticist, baseline eGFR ≥30 mL/min/1.73m², and urinary oxalate levels. Use

Do You Qualify for Hetlioz LQ Coverage by UnitedHealthcare in New Jersey? Complete Decision Tree & Appeals Guide

Answer Box: Your Fast Track to Hetlioz LQ Coverage To get Hetlioz LQ (tasimelteon oral suspension) covered by UnitedHealthcare in New Jersey: You need genetic confirmation of Smith-Magenis syndrome (17p11.2 deletion or RAI1 mutation), documented melatonin trial failure (typically 4-6 weeks), and prescription by a sleep specialist. Submit prior

How to Get Idelvion Covered by Aetna CVS Health in New Jersey: Prior Authorization Guide and Appeals Process

Answer Box: Getting Idelvion Covered by Aetna CVS Health in New Jersey Idelvion (albutrepenonacog alfa; rFIX-FP) requires prior authorization from Aetna CVS Health for hemophilia B treatment. Key requirements: confirmed Factor IX deficiency ≤2%, negative inhibitors (<0.6 BU), board-certified hematologist prescription, and specialty pharmacy dispensing through CVS Caremark.

Myths vs. Facts: Getting Ruconest (C1 Esterase Inhibitor) Covered by UnitedHealthcare in New Jersey

Answer Box: Getting Ruconest Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Ruconest (C1 esterase inhibitor [recombinant]) in New Jersey, with approval based on confirmed HAE diagnosis and specialist prescription—not automatic coverage myths. The fastest path: (1) Gather HAE lab results and attack documentation, (2) Have

How to Get Pemazyre (Pemigatinib) Covered by Cigna in New Jersey: Prior Authorization Forms, Appeal Scripts, and External Review Guide

Answer Box: Quick Path to Pemazyre Coverage To get Pemazyre (pemigatinib) covered by Cigna in New Jersey: 1) Have your doctor submit a prior authorization with FGFR2 fusion testing results, baseline eye exam, and documented prior therapy failures. 2) If denied, file an internal appeal within 180 days using Cigna&

Denied for Natpara by UnitedHealthcare in New Jersey? Complete 2025 Appeal Guide & Alternative Coverage Options

Answer Box: Natpara was discontinued by Takeda in December 2024, making new prescriptions impossible. If denied coverage for alternative parathyroid hormone treatments like Yorvipath, New Jersey patients can appeal through UnitedHealthcare's internal process (180 days), then New Jersey's Independent Health Care Appeals Program (IHCAP) via Maximus

How to Get Pombiliti (cipaglucosidase alfa-atga) Covered by Humana in New Jersey: Appeals Guide with Forms and Timelines

Answer Box: Getting Pombiliti Covered by Humana in New Jersey Pombiliti (cipaglucosidase alfa-atga) requires prior authorization from Humana and is not on their preferred formulary. Your fastest path to approval: (1) Submit a formulary exception request with comprehensive medical necessity documentation showing inadequate response to current ERT, (2) Request expedited